NCT00199810

Brief Summary

This trial is examining hemodynamic measurements in women with serious preeclampsia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2005

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
Last Updated

October 17, 2016

Status Verified

October 1, 2016

Enrollment Period

3.1 years

First QC Date

September 15, 2005

Last Update Submit

October 14, 2016

Conditions

Keywords

Cardiac outputPreeclamptic womensystemic vascular resistanceblood pressure

Outcome Measures

Primary Outcomes (1)

  • Hemodynamic variations in preeclamptic women

    days

Secondary Outcomes (2)

  • Urine output

    days

  • thrombocyte count

    days

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women with moderate-to-severe pre-eclampsia

You may qualify if:

  • Women with serious preeclampsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0027, Norway

Location

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Eldrid Langesæter Langesæter

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant, MD, PhD

Study Record Dates

First Submitted

September 15, 2005

First Posted

September 20, 2005

Study Start

July 1, 2005

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

October 17, 2016

Record last verified: 2016-10

Locations